title: [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
abstract: Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf. thomasius@uke.uni-hamburug.de
authors.forename: R
authors.initials: R
authors.lastname: Thomasius
authors.forename: E
authors.initials: E
authors.lastname: Gouzoulis-Mayfrank
authors.forename: C
authors.initials: C
authors.lastname: Karus
authors.forename: H
authors.initials: H
authors.lastname: Wiedenmann
authors.forename: L
authors.initials: L
authors.lastname: Hermle
authors.forename: P M
authors.initials: PM
authors.lastname: Sack
authors.forename: D
authors.initials: D
authors.lastname: Zeichner
authors.forename: U
authors.initials: U
authors.lastname: Küstner
authors.forename: A
authors.initials: A
authors.lastname: Schindler
authors.forename: A
authors.initials: A
authors.lastname: Krüger
authors.forename: S
authors.initials: S
authors.lastname: Uhlmann
authors.forename: K U
authors.initials: KU
authors.lastname: Petersen
authors.forename: P
authors.initials: P
authors.lastname: Zapletalova
authors.forename: L
authors.initials: L
authors.lastname: Wartberg
authors.forename: C G
authors.initials: CG
authors.lastname: Schütz
authors.forename: M
authors.initials: M
authors.lastname: Schulte-Markwort
authors.forename: J
authors.initials: J
authors.lastname: Obrocki
authors.forename: A
authors.initials: A
authors.lastname: Heinz
authors.forename: A
authors.initials: A
authors.lastname: Schmoldt
mesh_terms: D000328:Adult; D019969:Amphetamine-Related Disorders / Q000628:therapy*; D019970:Cocaine-Related Disorders / Q000628:therapy*; D015897:Comorbidity; D019317:Evidence-Based Medicine; D005260:Female; D006213:Hallucinogens; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D011247:Pregnancy; D019966:Substance-Related Disorders / Q000503:physiopathology / Q000628:therapy*
chemical_list: D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine